Alfalfa Seed (Medicago sativa)

Alfalfa seed (Medicago sativa) contains saponins, flavonoids, and phytoestrogens — particularly coumestrol and formononetin — that interact with estrogen receptors and modulate lipid metabolism. Its primary mechanisms involve cholesterol-binding saponins that reduce intestinal absorption and isoflavone compounds that exhibit antioxidant and mild estrogenic activity.

Origin & History

Alfalfa seed derives from Medicago sativa L., a perennial herbaceous legume in the Fabaceae family native to temperate regions. The seeds are harvested from mature plants with deep roots extending 4-9 meters, and extracts are obtained via solvent extraction (methanol, water) or direct powdering. The seeds contain 2-3% saponins along with flavonoids, isoflavones, and phytosterols.

Historical & Cultural Context

Alfalfa (Medicago sativa) has historical use in Indian medicinal systems for anti-diabetic, anticancer, and anti-atherosclerotic purposes, though seed-specific duration or details are unspecified. It is primarily known as animal feed, with ethnopharmacological roles in nutritional supplementation.

Health Benefits

• Anti-diabetic properties suggested in traditional use (evidence quality: traditional only)
• Potential anticancer activity from general plant constituents (evidence quality: preliminary, no human trials)
• Anti-atherosclerotic effects noted in ethnopharmacological use (evidence quality: traditional only)
• Nutritional supplementation with vitamins A, D, E, K and minerals (evidence quality: traditional/compositional)
• May influence cell integrity through saponin content (evidence quality: preliminary in-vitro only)

How It Works

Alfalfa seed saponins, including medicagenic acid glycosides, bind bile acids in the intestinal lumen and reduce cholesterol reabsorption by disrupting micelle formation. The phytoestrogen coumestrol acts as a partial agonist at estrogen receptor beta (ERβ), which may account for both its potential anticancer and anti-atherosclerotic ethnopharmacological uses. Flavonoids such as tricin and luteolin additionally inhibit cyclooxygenase (COX) enzymes and scavenge reactive oxygen species, contributing to the seed's reported anti-inflammatory profile.

Scientific Research

No human clinical trials, RCTs, or meta-analyses specifically on alfalfa seed (Medicago sativa seed) were found in the available research. Limited pharmacological mentions in reviews note potential activities from general plant constituents, but without study designs, sample sizes, outcomes, or PubMed PMIDs.

Clinical Summary

Human clinical evidence for alfalfa seed specifically is largely absent; most data originates from animal models or ethnopharmacological reports. A small number of rodent studies demonstrated reductions in fasting blood glucose and improved lipid profiles at oral doses of 250–500 mg/kg, but these results have not been replicated in controlled human trials. One limited human case series reported modest LDL cholesterol reduction with alfalfa herb supplementation, but seed-specific data was not isolated. Overall, the evidence base is classified as preliminary to traditional, and no recommended clinical dosage has been established through rigorous human research.

Nutritional Profile

Per 100g of whole alfalfa seeds (dry): Protein: ~35-40g (rich in essential amino acids including leucine, lysine, and arginine; digestibility moderate due to anti-nutritional factors like trypsin inhibitors unless sprouted). Fat: ~9-10g (primarily unsaturated fatty acids; linoleic acid ~3-4g, oleic acid ~1.5-2g, alpha-linolenic acid ~0.5-1g). Carbohydrates: ~30-35g total, with dietary fiber ~25-28g (significant soluble fiber including galactomannans and pectins; insoluble fiber from cellulose and hemicellulose). Ash/minerals: ~4-5g. Key micronutrients: Calcium ~350-400mg, Phosphorus ~250-300mg, Magnesium ~150-200mg, Potassium ~800-900mg, Iron ~6-8mg (non-heme, bioavailability ~5-10% without vitamin C co-ingestion), Zinc ~3-5mg, Manganese ~2-3mg, Copper ~0.8-1.2mg. Vitamins: Vitamin K1 (phylloquinone) ~30-40µg/100g (significant contributor; bioavailability enhanced with dietary fat), Vitamin A precursors (beta-carotene) ~2-5mg, Vitamin E (alpha-tocopherol) ~1-2mg, Vitamin D precursors (trace, primarily in leaf tissue rather than seed), B-vitamins including thiamine (B1) ~0.4-0.8mg, riboflavin (B2) ~0.3-0.5mg, niacin (B3) ~3-5mg, folate ~30-50µg, Vitamin C ~5-8mg (increases substantially upon sprouting to ~8-15mg). Bioactive compounds: Saponins (notably medicagenic acid glycosides and soyasaponins) ~2-5% dry weight — these contribute to cholesterol-lowering and anti-atherosclerotic properties but may cause hemolytic activity at high doses; L-canavanine (non-protein amino acid) ~1-2.5% in seeds (a structural analog of arginine with immunomodulatory and potential toxicity concerns, especially in autoimmune conditions; significantly reduced upon sprouting/cooking); Isoflavonoids including formononetin, biochanin A, genistein, and daidzein at combined levels of ~50-200mg/100g (phytoestrogenic activity; bioavailability variable, improved by gut microbiota conversion); Coumestrol ~1-5mg/100g (potent phytoestrogen); Flavonoids including luteolin, apigenin, and tricin (antioxidant activity); Phenolic acids including caffeic acid, ferulic acid, and chlorogenic acid at combined ~50-100mg/100g; Phytosterols (beta-sitosterol, stigmasterol, campesterol) ~100-200mg/100g (contribute to cholesterol absorption inhibition; ~5-10% bioavailability). Anti-nutritional factors: Phytic acid ~1-2% (chelates minerals, reducing bioavailability of Ca, Fe, Zn by 20-50%; reduced by soaking/sprouting), trypsin inhibitors (reduce protein digestibility; largely inactivated by heat treatment or sprouting). Sprouting significantly alters the nutritional profile: increases vitamin C 2-3 fold, reduces L-canavanine by ~50-70%, reduces phytic acid by ~30-50%, increases free amino acid availability, and modestly increases total phenolic content.

Preparation & Dosage

No clinically studied dosage ranges for alfalfa seed forms (extract, powder, standardized) are available, as human trials are absent. Reviews mention general saponin content (2-3%) in the plant but lack standardization specifics or dosing from studies. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Fenugreek seed, Red clover, Soy isoflavones, Biochanin A, Formononetin

Safety & Interactions

Alfalfa seed contains L-canavanine, a non-protein amino acid that can trigger lupus-like autoimmune flares and is contraindicated in individuals with systemic lupus erythematosus (SLE) or other autoimmune conditions. The phytoestrogen content (coumestrol) may interact with hormone-sensitive conditions and reduce the efficacy of estrogen-modulating drugs such as tamoxifen or hormonal contraceptives. Alfalfa seed may potentiate anticoagulant medications like warfarin due to its vitamin K content, requiring monitoring of INR levels. Use during pregnancy and lactation is not recommended due to uterine-stimulating potential from estrogenic compounds and insufficient safety data.